BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 22364653)

  • 1. Prurigo as a symptom of atopic and non-atopic diseases: aetiological survey in a consecutive cohort of 108 patients.
    Iking A; Grundmann S; Chatzigeorgakidis E; Phan NQ; Klein D; Ständer S
    J Eur Acad Dermatol Venereol; 2013 May; 27(5):550-7. PubMed ID: 22364653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xerosis cutis and associated co-factors in women with prurigo nodularis.
    Akarsu S; Ozbagcivan O; Ilknur T; Semiz F; Inci BB; Fetil E
    An Bras Dermatol; 2018; 93(5):671-679. PubMed ID: 30156616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive prurigo nodularis: characterization and etiology.
    Tan WS; Tey HL
    Dermatology; 2014; 228(3):276-80. PubMed ID: 24662043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prurigo nodularis in a 9-year-old girl.
    Amer A; Fischer H
    Clin Pediatr (Phila); 2009 Jan; 48(1):93-5. PubMed ID: 18648078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori and prurigo nodularis.
    Neri S; Ierna D; D'Amico RA; Giarratano G; Leotta C
    Hepatogastroenterology; 1999; 46(28):2269-72. PubMed ID: 10521979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological factors in prurigo nodularis in comparison with psoriasis vulgaris: results of a case-control study.
    Schneider G; Hockmann J; Ständer S; Luger TA; Heuft G
    Br J Dermatol; 2006 Jan; 154(1):61-6. PubMed ID: 16403095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of prurigo nodularis with pregabalin.
    Mazza M; Guerriero G; Marano G; Janiri L; Bria P; Mazza S
    J Clin Pharm Ther; 2013 Feb; 38(1):16-8. PubMed ID: 23013514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell profiling of prurigo nodularis demonstrates immune-stromal crosstalk driving profibrotic responses and reversal with nemolizumab.
    Ma F; Gharaee-Kermani M; Tsoi LC; Plazyo O; Chaskar P; Harms P; Patrick MT; Xing X; Hile G; Piketty C; Lazzari A; Van Delm W; Maverakis E; Nakamura M; Modlin RL; Kahlenberg JM; Billi AC; Julia V; Krishnaswamy JK; Gudjonsson JE
    J Allergy Clin Immunol; 2024 Jan; 153(1):146-160. PubMed ID: 37506977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UVB 308-nm excimer light and bath PUVA: combination therapy is very effective in the treatment of prurigo nodularis.
    Hammes S; Hermann J; Roos S; Ockenfels HM
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):799-803. PubMed ID: 20946583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prurigo nodularis: a benign dermatosis derived from a persistent pruritus.
    Vaidya DC; Schwartz RA
    Acta Dermatovenerol Croat; 2008; 16(1):38-44. PubMed ID: 18358109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prurigo nodularis: systematic analysis of 58 histological criteria in 136 patients.
    Weigelt N; Metze D; Ständer S
    J Cutan Pathol; 2010 May; 37(5):578-86. PubMed ID: 20002240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prurigo nodularis as a sweat gland/duct-related disorder: resolution associated with restoration of sweating disturbance.
    Katayama C; Hayashida Y; Sugiyama S; Shiohara T; Aoyama Y
    Arch Dermatol Res; 2019 Sep; 311(7):555-562. PubMed ID: 31152230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics and Treatment Outcomes of Prurigo Nodularis: A Retrospective Study.
    Taghaddos D; Savinova I; Abu-Hilal M
    J Cutan Med Surg; 2024; 28(2):141-145. PubMed ID: 38281092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychosomatic aspects of prurigo nodularis].
    Schneider G; Hockmann J; Stumpf A
    Hautarzt; 2014 Aug; 65(8):704-8. PubMed ID: 25113329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological factors involved in prurigo nodularis: A pilot study.
    Dazzi C; Erma D; Piccinno R; Veraldi S; Caccialanza M
    J Dermatolog Treat; 2011 Aug; 22(4):211-4. PubMed ID: 20666670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prurigo nodularis: an update on etiopathogenesis and therapy.
    Fostini AC; Girolomoni G; Tessari G
    J Dermatolog Treat; 2013 Dec; 24(6):458-62. PubMed ID: 23767411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cardiovascular risks and mortality in prurigo nodularis: a global cohort study.
    Olbrich H; Kridin K; Hernández G; Zirpel H; Sadik CD; Terheyden P; Thaçi D; Ludwig RJ; Boch K
    EBioMedicine; 2024 May; 103():105123. PubMed ID: 38631094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnic differences and comorbidities of 909 prurigo nodularis patients.
    Boozalis E; Tang O; Patel S; Semenov YR; Pereira MP; Stander S; Kang S; Kwatra SG
    J Am Acad Dermatol; 2018 Oct; 79(4):714-719.e3. PubMed ID: 29733939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment-resistant prurigo nodularis: challenges and solutions.
    Kowalski EH; Kneiber D; Valdebran M; Patel U; Amber KT
    Clin Cosmet Investig Dermatol; 2019; 12():163-172. PubMed ID: 30881076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monochromatic excimer light (308 nm) in the treatment of prurigo nodularis.
    Saraceno R; Nisticò SP; Capriotti E; de Felice C; Rhodes LE; Chimenti S
    Photodermatol Photoimmunol Photomed; 2008 Feb; 24(1):43-5. PubMed ID: 18201357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.